Companies / BOC Sciences / Adalimumab
BOC Sciences

Adalimumab | BOC Sciences

Adalimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF_). Adalimumab has been used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.